AstraZeneca’s Forxiga gets EU approval recommendation for symptomatic chronic heart failure
December 19, 2022 at 03:27 AM EST
The recommendation covers heart failure with reduced ejection fraction--a measure of the amount of blood the heart's left ventricle pumps with each heartbeat.
